Evaluation of the effects of ginger consumption on eradication of H.pylori, clinical symptoms, inflammatory factors, and oxidative stress in patients with peptic ulcer

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2023
INTERVENTION: Intervention 1: Intervention group: will take 2g of ginger daily in the form of four tablets each contains 500 mg of ginger (Product of Dine Company) orally for si Xweeks. Intervention 2: Control group: will take four placebo tablets daily, which are similar in shape and taste to ginger tablet,orally for 6 weeks. CONDITION: Peptic ulcer. ; Peptic ulcer, site unspecified PRIMARY OUTCOME: Anti‐oxidant status. Timepoint: 8 week. Method of measurement: ELISA. Clinical Symptoms. Timepoint: 8 week. Method of measurement: Questionnaire. H.Pylori eradication. Timepoint: 8 week. Method of measurement: Endoscopy and Pathology. INCLUSION CRITERIA: General desire to practice the study Age over 18 years and less than 80 years Confirmation of H. pylori infection by stool antigen test or endoscopic pathology findings No antibiotic use in the last 4 weeks No active alcohol consumption or alcohol, corticosteroid and anticoagulant use No diseases Cardiovascular, liver, lung, kidney, malignancy Absence of recent surgery Absence of pregnancy or breastfeeding in women Absence of allergy to H pylori infection eradication regimen
Epistemonikos ID: 07da98493f1034dfbf4e2f7a911c6f2ad2198da5
First added on: Feb 20, 2024